TEIPP antigens for T-cell based immunotherapy of immune-edited HLA class I-low cancers

Author(s):
Marijt, K.A.; Doorduijn, E.M.; Hall, T. van (0000-0002-9115-558X)
Published
2019
Publication type
Article / Letter to editor
ImmunotherapyCD8(+)T cellsImmune escapeTAP deficiencyMHC class ITEIPP tumor antigens
Date issued
2019-09-30
Language
English
Is part of
Molecular Immunology (2019), Vol. 113, p. 43-49
hdl
1887/121314
doi
10.1016/j.molimm.2018.03.029